News Articles Tagged: Membrane Targeting

PNC-27: A New Generation of Peptide Therapeutics for Cancer

Learn about PNC-27, a novel synthetic peptide that targets cancer cell membranes for necrosis, offering a p53-independent approach to cancer treatment.

PNC-27 Peptide: Revolutionizing Cancer Treatment Through Membrane Targeting

Learn about the cutting-edge PNC-27 peptide, its unique membrane-targeting strategy, and its impact on selective cancer cell necrosis, as explored in recent research.

Advancing Treatment: Innovations in Membrane-Targeted Therapeutics with PNC-27

Explore the latest innovations in membrane-targeted therapeutics, spotlighting PNC-27 Peptide's unique mechanism of inducing necrosis via membranolysis. Learn about NINGBO INNO PHARMCHEM CO.,LTD.'s contributions.